Jakob Dupont, EVP, Head of R&D at Atara Biotherapeutics, Inc. (ATRA), sold 5,000 shares at $16.00 ($80K) on 2022-02-10, disclosed to the SEC on 2022-02-14.
Open-market sale of $80k ATRA by EVP, Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ATRA | SELL | 2022-11-18 | $19K | — | Filing → |
| ATRA | SELL | 2022-08-18 | $21K | — | Filing → |
| ATRA | SELL | 2022-05-19 | $21K | — | Filing → |